CLINICAL ROLE -
Innovating Health Care: The Autonomous Pharmacy's Impact on Patient Care
Read More
Spotlight: NACDS Foundation Ensures Research Leads to Positive Clinical Outcomes
Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.
Watch
Intravenous Immunoglobulin Shows Beneficial Effects In Post-Menopausal Osteoporosis, Indicating Potential as Treatment
The use of intravenous immunoglobulin led to positive protective effects on osteoporosis.
Expert Discusses PBM Transparency, Balancing Competition, and Real-Time Optimization
Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.
IMPT-514 Receives Investigational New Drug Clearance From the FDA
The bispecific CAR T-cell therapy for treatment of multiple sclerosis is the first to target both CD19 and CD20.
Proposed Bill Requires States to Use Opioid Settlement Funds to Address the Opioid Epidemic
The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.
Overturning Chevron Deference Could Lead to Confusion, Chaos Across Pharmaceutical Industry
The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.
Walmart Launches Autoimmune-Focused Specialty Pharmacies of the Community
These pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.
Expert Insights: The Impact of the Updated Performance and Quality Measures for Patients with Heart Failure
Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.
GSK5764227 Receives Breakthrough Therapy Designation to Treat Extensive-Stage Small–Cell Lung Cancer
The breakthrough therapy designation was granted based on ongoing data from the ARTEMIS-001 phase 1 open-label, multi-center trial.
The Role of Site Management Organizations in Clinical Trial Management
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Propofol Injectable Emulsion Single-Dose Vials Receive FDA Approval
Propofol has a history of chronic shortage due to supply chain constraints.
Expert: Emphasis on Diabetes Research Can Close Gaps in Marginalized Communities
Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.
Expert Discusses Navigating Complexities of PBM Regulations
Brandon Newman discusses the significant influence of the "big 3" pharmacy benefit managers and the key legislative and regulatory efforts around transparency.
FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors
Vimseltinib (Deciphera Pharmaceuticals) has a Prescription Drug User Fee Act goal date of February 17, 2025.
Product News: August 2024
Winrevair From Merck
FDA Grants Orphan Drug, Fast Track Designation to RLS-0071 for aGVHD
The drug is currently undergoing a phase 2 clinical trial for patient 12 years or older who are hospitalized with steroid-refractory acute graft-versus-host disease (aGVHD).
FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC
The combination is the first and only multi-targeted chemotherapy-free regimen that demonstrated superiority compared with osimertinib for non–small cell lung cancer (NSCLC).
Integration of Palliative Pharmacists to Elevate Oncologic Care
Palliative pharmacists are invaluable assets of oncologic care.
AR882 Receives Fast Track Designation From the FDA for Treatment of Clinically Visible Tophaceous Gout
The highly potent, selective URAT1 inhibitor may help reduce serum uric acid levels and treat clinically visible tophi.
Pharmacists Can Play a Pivotal Role in Providing Value-Based Care
In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.
NACDS President Discusses Themes, Highlights of Total Store Expo
Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.
Analysis Finds Bidirectional Association Between Asthma and Psoriasis
The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.
FDA Grants Breakthrough Therapy Designation to DS-8201a and T-DXd to Treat Metastatic Breast Cancer
Fam-trastuzumab deruxtecan-nxki has received 4 breakthrough therapy designations, including the latest approval.
FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma
Currently, the drug will be studied in the SKYBRIDGE (NCT05652686) trial, a first-in-human, phase 1/2, open-label, dose-escalation and expansion study.
Five Quick Facts to Know About Biosimilars
The biosimilar space continues to grow, with key focuses around retina and oncology, but adoption remains slow in the United States.
First At-Home Syphilis Test Receives Marketing Authorization From the FDA
The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.
Researchers Identify Predictors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease
Noticing indicators of IVIG non-responsiveness can lead to better outcomes among patients with Kawasaki disease as treatment is adjusted.
New First-Line Options Emerging for Type 2 Diabetes Care
Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin
